MA45159A - Polypeptides d'hémagglutinine d'influenza modifiés - Google Patents

Polypeptides d'hémagglutinine d'influenza modifiés

Info

Publication number
MA45159A
MA45159A MA045159A MA45159A MA45159A MA 45159 A MA45159 A MA 45159A MA 045159 A MA045159 A MA 045159A MA 45159 A MA45159 A MA 45159A MA 45159 A MA45159 A MA 45159A
Authority
MA
Morocco
Prior art keywords
influenza hemagglutinin
hemagglutinin polypeptides
modified influenza
modified
polypeptides
Prior art date
Application number
MA045159A
Other languages
English (en)
Inventor
Eliud Oloo
Raymond Oomen
Tod Strugnell
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of MA45159A publication Critical patent/MA45159A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA045159A 2016-06-03 2017-06-02 Polypeptides d'hémagglutinine d'influenza modifiés MA45159A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662345502P 2016-06-03 2016-06-03

Publications (1)

Publication Number Publication Date
MA45159A true MA45159A (fr) 2019-04-10

Family

ID=59093612

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045159A MA45159A (fr) 2016-06-03 2017-06-02 Polypeptides d'hémagglutinine d'influenza modifiés

Country Status (14)

Country Link
US (2) US11116832B2 (fr)
EP (1) EP3464327A1 (fr)
JP (3) JP7110119B2 (fr)
KR (2) KR102731582B1 (fr)
CN (2) CN109563138B (fr)
AU (2) AU2017275663B2 (fr)
BR (1) BR112018075078A2 (fr)
CA (1) CA3026094A1 (fr)
EA (1) EA201892385A1 (fr)
IL (2) IL263416B2 (fr)
MA (1) MA45159A (fr)
MX (2) MX2018014887A (fr)
SG (2) SG10201913650WA (fr)
WO (1) WO2017210592A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110106193B (zh) * 2019-05-23 2021-11-12 广州医科大学 一种具有低受体结合活性的高致病性h7n9禽流感病毒抗原及其制备方法
CN110106192B (zh) * 2019-05-23 2021-11-12 广州医科大学 一种具有低受体结合活性的高致病性h7n9禽流感病毒抗原及其制备方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
CA1283827C (fr) 1986-12-18 1991-05-07 Giorgio Cirelli Dispositif pour l'injection de formules liquides
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (fr) 1994-03-07 1995-09-14 Bioject, Inc. Dispositif de remplissage d'ampoule
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
EP1167379A3 (fr) 1994-07-15 2004-09-08 University Of Iowa Research Foundation Oligonucléotides immunomodulateurs
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
WO1998037919A1 (fr) 1997-02-28 1998-09-03 University Of Iowa Research Foundation UTILISATION D'ACIDES NUCLEIQUES CONTENANT DES DINUCLEOTIDES CpG NON METHYLES DANS LE TRAITEMENT DES TROUBLES ASSOCIES AUX LIPOPOLYSACCHARIDES
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
EP1003531B1 (fr) 1997-05-20 2007-08-22 Ottawa Health Research Institute Procedes de preparation de constructions d'acides nucleiques
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
AU760549B2 (en) 1998-04-03 2003-05-15 University Of Iowa Research Foundation, The Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
US7566458B2 (en) 2003-06-16 2009-07-28 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US7566454B2 (en) 2005-02-24 2009-07-28 University Of Massachusetts Influenza nucleic acids, polypeptides, and uses thereof
EP2044198A4 (fr) 2006-07-27 2010-09-08 Ligocyte Pharmaceuticals Inc Particules de type virus grippal chimérique
US20120219584A1 (en) * 2009-10-05 2012-08-30 The United States Of America As Represented By The Secretary, Department Of Health Protection against pandemic and seasonal strains of influenza
KR101262300B1 (ko) * 2009-10-06 2013-05-20 헬릭스 주식회사 형질전환 식물 유래의 고병원성 조류독감 바이러스 단백질 백신 및 그 제조방법
US8883171B2 (en) 2010-09-14 2014-11-11 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for influenza
WO2012106231A2 (fr) 2011-01-31 2012-08-09 Baxter International Inc. Vecteurs viraux recombinants et procédés d'induction d'une réponse immunitaire hétéro sous-typique aux virus de la grippe a
US9580475B2 (en) 2011-06-20 2017-02-28 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for H1N1 influenza
EP4241785B1 (fr) 2011-09-20 2026-01-28 Icahn School of Medicine at Mount Sinai Vaccins contre le virus de la grippe et leurs utilisations
EP2758038B1 (fr) 2011-09-23 2018-05-30 The United States of America, as represented by The Secretary, Department of Health & Human Services Nouveaux vaccins à base de protéine hémagglutinine de la grippe
CN103221064B (zh) * 2011-11-23 2014-12-03 苏州工业园区唯可达生物科技有限公司 抗流感病毒的免疫方法及其组合疫苗
WO2013119683A1 (fr) * 2012-02-07 2013-08-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Antigènes à large spectre optimisés in silico pour les virus grippaux de type h3n2, h2n2 et b
CA2863949C (fr) * 2012-02-13 2021-06-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Antigenes largement reactifs optimises par ordinateur pour la grippe h5n1 humaine et aviaire
CA2868330A1 (fr) * 2012-03-30 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Antigenes reactifs a large spectre optimises par le calcul pour des virus de la grippe h5n1 et h1n1
SG11201503989PA (en) 2012-11-27 2015-06-29 Univ Pittsburgh Computationally optimized broadly reactive antigens for h1n1 influenza
SG11201504728RA (en) 2012-12-18 2015-07-30 Icahn School Med Mount Sinai Influenza virus vaccines and uses thereof
US20140286981A1 (en) 2013-03-14 2014-09-25 Wisconsin Alumni Research Foundation Broadly reactive mosaic peptide for influenza vaccine
US9975925B2 (en) 2013-08-28 2018-05-22 Glaxosmithkline Biologicals S.A. Influenza antigens and antibodies

Also Published As

Publication number Publication date
IL263416A (en) 2019-01-31
SG10201913650WA (en) 2020-03-30
JP7110119B2 (ja) 2022-08-01
US11904012B2 (en) 2024-02-20
AU2017275663A1 (en) 2018-12-13
AU2022201514A1 (en) 2022-03-24
KR20190039065A (ko) 2019-04-10
CN109563138A (zh) 2019-04-02
SG11201810758WA (en) 2018-12-28
MX2023008256A (es) 2023-07-19
US11116832B2 (en) 2021-09-14
WO2017210592A1 (fr) 2017-12-07
MX2018014887A (es) 2019-06-06
AU2022201514B2 (en) 2024-02-15
US20220054623A1 (en) 2022-02-24
CN109563138B (zh) 2022-09-23
BR112018075078A2 (pt) 2019-03-06
IL263416B2 (en) 2024-10-01
IL263416B1 (en) 2024-06-01
CA3026094A1 (fr) 2017-12-07
KR102731582B1 (ko) 2024-11-15
KR20230061583A (ko) 2023-05-08
JP2020141703A (ja) 2020-09-10
KR102529010B1 (ko) 2023-05-04
JP2022153591A (ja) 2022-10-12
US20200215182A1 (en) 2020-07-09
JP7479424B2 (ja) 2024-05-08
CN115746107A (zh) 2023-03-07
AU2017275663B2 (en) 2021-12-09
IL312520A (en) 2024-07-01
JP2019525733A (ja) 2019-09-12
EP3464327A1 (fr) 2019-04-10
EA201892385A1 (ru) 2019-06-28

Similar Documents

Publication Publication Date Title
EP3538146A4 (fr) Vaccin antigrippal
MA46041A (fr) Anticorps anti-tim -3
EP3485773A4 (fr) Buse d'aspirateur
EP3430731A4 (fr) Architecture d'iugw
PL3649151T3 (pl) Białka rusztowania
EP3359573A4 (fr) Marquage d'anticorps
PT3723783T (pt) Péptidos dirigidos à mitocôndria
EP3422155A4 (fr) Contrôleur d'objet
MA44236A (fr) Anticorps anti-tgfbêta 2
EP3394754A4 (fr) Planification d'applications fortement parallèles
EP3528827A4 (fr) Vaccins contre la grippe à base de protéine hémagglutinine
DK3407944T3 (da) Forstøver
EP3457004A4 (fr) Structure d'étanchéité
EP3431808A4 (fr) Butée d'arrêt
EP3450026A4 (fr) Pulvérisateur à gâchette
EP3554717C0 (fr) Appareil de pulvérisation
EP3445974A4 (fr) Réchauffeur d'air
EP3257417C0 (fr) Buse d'aspirateur
EP3444345A4 (fr) Dérivé d'arnmicro-143
EP3466546A4 (fr) Pulvériseur à gâchette
DK3343570T3 (da) 68GE/68GA-generator
IL260897B (en) Aerosol valve configurations
EP3562498A4 (fr) Vaccins contre la grippe
EP3509755A4 (fr) Pulvérisateur à gâchette
EP3423090C0 (fr) Nouveaux antigènes de la grippe